Difficulty: Medium
Average Score: 95%
Practice
To be effective in ulcerative colitis, 5-aminosalicylic acid has to be given as
Correct answer
D
Rationale
In the treatment of ulcerative colitis, the correct method of administering 5-aminosalicylic acid (5-ASA) is crucial for its effectiveness. Option D, "All of the above," is the correct choice because 5-ASA can be given in various formulations to target different areas of the gastrointestinal tract.
A) The acrylic polymer coated tablet is designed to release the drug only in the lower bowel, where it is needed to treat ulcerative colitis. This targeted delivery system helps maximize the therapeutic effect of the drug while minimizing systemic side effects.
B) A complex of two molecules joined together by an azo bond is another formulation of 5-ASA that can be used in the treatment of ulcerative colitis. This formulation allows for controlled release of the drug in the colon, where it exerts its anti-inflammatory effects.
C) A retention enema is a local delivery method for 5-ASA that allows for direct administration of the drug into the rectum and colon. This can be particularly beneficial for patients with distal colitis or proctitis.
Educationally, understanding the different formulations and modes of administration of 5-ASA in the treatment of ulcerative colitis is important for healthcare professionals to optimize patient outcomes. By tailoring the delivery of 5-ASA to the location and severity of inflammation in the gastrointestinal tract, healthcare providers can provide more effective and targeted treatment while minimizing systemic side effects. This knowledge empowers healthcare professionals to make informed decisions about the most appropriate therapy for patients with ulcerative colitis.
A) The acrylic polymer coated tablet is designed to release the drug only in the lower bowel, where it is needed to treat ulcerative colitis. This targeted delivery system helps maximize the therapeutic effect of the drug while minimizing systemic side effects.
B) A complex of two molecules joined together by an azo bond is another formulation of 5-ASA that can be used in the treatment of ulcerative colitis. This formulation allows for controlled release of the drug in the colon, where it exerts its anti-inflammatory effects.
C) A retention enema is a local delivery method for 5-ASA that allows for direct administration of the drug into the rectum and colon. This can be particularly beneficial for patients with distal colitis or proctitis.
Educationally, understanding the different formulations and modes of administration of 5-ASA in the treatment of ulcerative colitis is important for healthcare professionals to optimize patient outcomes. By tailoring the delivery of 5-ASA to the location and severity of inflammation in the gastrointestinal tract, healthcare providers can provide more effective and targeted treatment while minimizing systemic side effects. This knowledge empowers healthcare professionals to make informed decisions about the most appropriate therapy for patients with ulcerative colitis.